We are live on
!
Find out more
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
ONCE
Delisted
ONCE was delisted on the 16th of December, 2019.
90 hedge funds and large institutions have $622M invested in Spark Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
58% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 24
17% less funds holding
Funds holding: 109 → 90 (-19)
29% less capital invested
Capital invested by funds: $872M → $622M (-$251M)
42% less call options, than puts
Call options by funds: $20.1M | Put options by funds: $34.7M
56% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 32
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
90
Holders Change
-19
Holders Change %
-17.43%
% of All Funds
2.51%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
38
Reduced
24
Closed
32
Calls
$20.1M
Puts
$34.7M
Net Calls
-$14.6M
Net Calls Change
-$12M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$45.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.5M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$15.3M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$10.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$9.71M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$38M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.5M |
| 3 |
O
OrbiMed
New York
|
-$10M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$9.42M |
| 5 |
Millennium Management
New York
|
-$8.88M |
